person

Thierry A.

Country
France
Department
Service d’oncologie médicale

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
298
Sites with multiple studies

Has run more than one trial at 298 of 548 partner sites.

Specializations

Colorectal Cancer Studies

The investigator specializes in treating various forms of colorectal cancer, with particular emphasis on advanced and metastatic cases. Their research encompasses both early-stage colon cancer and metastatic colorectal cancer (mCRC).

  • MSI-H/dMMR colorectal cancer treatments
  • BRAF V600E-mutant therapies
  • KRAS/NRAS wild-type treatments
  • Circulating tumor DNA analysis

The investigator works with novel therapeutic combinations including immunotherapy and targeted treatments for various molecular subtypes of colorectal cancer.

Gastric Cancer Research

The investigator focuses on treating gastric and gastroesophageal junction (GEJ) adenocarcinoma, exploring innovative therapeutic approaches for both locally advanced and metastatic disease.

  • HER2-positive gastric cancer
  • Perioperative treatment strategies
  • CLDN18.2-positive gastric cancer
  • Immunotherapy applications

Their work includes evaluation of novel treatment combinations and targeted therapies for gastric cancer patients.

Advanced Solid Tumors

The investigator conducts research on advanced solid tumors with specific genetic alterations and explores innovative therapeutic approaches across multiple cancer types.

  • NTRK fusion-positive tumors
  • Immunotherapy combinations
  • Novel therapeutic agents
  • Molecular targeting strategies

Their research includes evaluation of treatment responses in various molecular subtypes of solid tumors.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.